Terms: = Breast cancer AND CEACAM5, CEA AND Diagnosis
468 results:
1. Development and validation of a model and nomogram for breast cancer diagnosis based on quantitative analysis of serum disease-specific haptoglobin N-glycosylation.
Li L; Xu Y; Lai Z; Li D; Sun Q; Li Z; Zhou Y
J Transl Med; 2024 Apr; 22(1):331. PubMed ID: 38575942
[TBL] [Abstract] [Full Text] [Related]
2. [Long-Term Suppression with First-Line Chemotherapy(FOLFIRI plus BV)for Peritoneal Metastasis].
Teranishi N; Inagaki S; Yoshida H; Nagasawa S; Takane Y; Yan M; Takahashi M; Masubuchi M; Wakabayashi K; Uetake H; Itoh Y
Gan To Kagaku Ryoho; 2024 Feb; 51(2):199-201. PubMed ID: 38449412
[TBL] [Abstract] [Full Text] [Related]
3. sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
4. Serum human epidermal growth factor receptor-2 extracellular domain, carcinoma embryonic antigen and carbohydrate antigen 15-3 combined detection in early diagnosis of breast cancer.
Yuan Q; Song JY; Ye LQ; Zhang YM
J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085516
[TBL] [Abstract] [Full Text] [Related]
5. Machine learning-based models for the prediction of breast cancer recurrence risk.
Zuo D; Yang L; Jin Y; Qi H; Liu Y; Ren L
BMC Med Inform Decis Mak; 2023 Nov; 23(1):276. PubMed ID: 38031071
[TBL] [Abstract] [Full Text] [Related]
6. FTO, PIK3CB serve as potential markers to complement cea and CA15-3 for the diagnosis of breast cancer.
Mi J; Zhang H; Cao W; Yuan C
Medicine (Baltimore); 2023 Oct; 102(42):e35361. PubMed ID: 37861518
[TBL] [Abstract] [Full Text] [Related]
7. The Leser-Trélat Sign in a Patient with Gastric Adenocarcinoma.
Geber A; Hadžavdić A; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2023 Aug; 31(1):51-52. PubMed ID: 37843094
[TBL] [Abstract] [Full Text] [Related]
8. MOF-Based Biosensors for the Detection of Carcinoembryonic Antigen: A Concise Review.
Ibrahim MR; Greish YE
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630221
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of Serum Fructosamine as Diagnostic Marker of Postoperative Recurrence in the Patients with breast cancer.
Zhao Y; Xie X; Xie J; Zhang L; Li B; Liu J; Jiang H
Biomed Res Int; 2023; 2023():6435776. PubMed ID: 37475819
[TBL] [Abstract] [Full Text] [Related]
10. Ultrasensitive immunosensor for multiplex detection of cancer biomarkers carcinoembryonic antigen (cea) and yamaguchi sarcoma viral oncogene homolog 1 (YES1) based on eco-friendly synthesized gold nanoparticles.
Kiio LK; Onyatta JO; Ndangili PM; Oloo F; Santamaria C; Montuenga LM; Mbui DN
Talanta; 2024 Jan; 266(Pt 1):124934. PubMed ID: 37454512
[TBL] [Abstract] [Full Text] [Related]
11. The role of circulating cell-free DNA and its integrity as a biomarker for diagnosis of breast cancer using ALU (247/115) bP sequences.
Abd El Hafeez HA; Abd El Rahman MZ; Kamel TM; Rezk KM; Mohamed FM; Abdel-Hameed ZA
Egypt J Immunol; 2023 Jul; 30(3):44-55. PubMed ID: 37439529
[TBL] [Abstract] [Full Text] [Related]
12. Facile preparation of Ru nanoassemblies for electrochemical immunoassay of carcinoembryonic antigen in clinical serum.
Sun HN; Mou LL; Tan YY; Liu M; Li SS
Anal Biochem; 2023 Sep; 676():115234. PubMed ID: 37422060
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA Dysregulation in Early breast cancer diagnosis: A Systematic Review and Meta-Analysis.
Garrido-Palacios A; Rojas Carvajal AM; Núñez-Negrillo AM; Cortés-Martín J; Sánchez-García JC; Aguilar-Cordero MJ
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175974
[TBL] [Abstract] [Full Text] [Related]
14. [Biomarkers for early screening and diagnosis of breast cancer: a review].
Liang Y; Hao M; Guo R; Li X; Li Y; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1425-1444. PubMed ID: 37154315
[TBL] [Abstract] [Full Text] [Related]
15. Goblet cell adenocarcinoma of the anal canal with perianal Paget disease: A rare case report with literature review.
Li M; Yao X
Medicine (Baltimore); 2023 Apr; 102(16):e33598. PubMed ID: 37083794
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic role of heart rate variability in breast cancer and its relationship with peripheral serum carcinoembryonic antigen.
Ding L; Yang Y; Chi M; Chen Z; Huang Y; Ouyang W; Li W; He L; Wei T
PLoS One; 2023; 18(4):e0282221. PubMed ID: 37023015
[TBL] [Abstract] [Full Text] [Related]
17. Integrated SERS-Vertical Flow Biosensor Enabling Multiplexed Quantitative Profiling of Serological Exosomal Proteins in Patients for Accurate breast cancer Subtyping.
Su X; Liu X; Xie Y; Chen M; Zheng C; Zhong H; Li M
ACS Nano; 2023 Feb; 17(4):4077-4088. PubMed ID: 36758150
[TBL] [Abstract] [Full Text] [Related]
18. Dual-Channel Detection of breast cancer Biomarkers CA15-3 and cea in Human Serum Using Dialysis-Silicon Nanowire Field Effect Transistor.
Li H; Wang S; Li X; Cheng C; Shen X; Wang T
Int J Nanomedicine; 2022; 17():6289-6299. PubMed ID: 36536938
[TBL] [Abstract] [Full Text] [Related]
19. Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HCs, and TNBC versus non-TNBC.
Jin Y; Fan S; Jiang W; Zhang J; Yang L; Xiao J; An H; Ren L
Proteomics Clin Appl; 2023 May; 17(3):e2200042. PubMed ID: 36443927
[TBL] [Abstract] [Full Text] [Related]
20. Old and New Blood Markers in Human Colorectal cancer.
Wautier JL; Wautier MP
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361758
[TBL] [Abstract] [Full Text] [Related]
[Next]
